Table 1 Summary of patient characteristics
From: Prognostic impact of CT severity score in childhood cancer with SARS-CoV-2
| Â | Characteristic | All patients (N = 64) (%) | Mild (N = 45) (%) | Moderate-severe (N = 19) | P value |
|---|---|---|---|---|---|
Sex, no. of patients | Male | 35 (54.6%) | 26 (57.7%) | 9 (47.3%) | 0.6242 |
Female | 29 (45.4%) | 19 (42.3%) | 10 (52.7) % | ||
Age range | < 5 years | 14 (21.87%) | 11 (24.4%) | 3 (15.7%) | 0.4692 |
5-10 | 27 (42.18%) | 20 (44.4%) | 7 (36.8%) | ||
11-18 years | 23 (35.9%) | 14 (31.1%) | 9 (47.3%) | ||
Symptoms | Fever | 59 (92.1%) | 41 (91.1%) | 18 (94.7%) | 11 |
Cough | 36 (56.25%) | 24 (53.3%) | 12 (63.15%) | 0.6542 | |
Abdominal symptoms | 8 (12.5%) | 4 (8.8 %) | 4 (21%) | 0.2231 | |
Dyspnea | 24 (37.5%) | 5 (11.1%) | 19 (100%) | < 0.051 | |
Loss of smell and taste | 26 (40.62%) 16 not identified | 22 (48.8%) | 4 (21%) | < 0.051* | |
Type of primary tumor | Hematological | 54 (84.37%) | 42 (93.3 %) | 15 (79%) | 0.1821 |
Solid tumor | 7 (10.93%) | 3 (6.6%) | 4 (21%) |